✦ LIBER ✦

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity

✍ Scribed by William Frishman; John Kostis; Joel Strom; Maryhelen Hossler; Uri Elkayam; Susan Goldner; Ralph Silverman; Richard Davis; Jerome Weinstein; Edmund Sonnenblick

Book ID: 115655593
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 268 KB
Volume: 98
Category: Article
ISSN: 1097-6744
DOI: 10.1016/0002-8703(79)90261-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of the new beta-ad

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience

✍ Stanley Halprin; William Frishman; Marc Kirschner; Joel Strom 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Clinical pharmacology of the new beta-ad

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm

✍ William Frishman; Richard Davis; Joel Strom; Uri Elkayam; Morris Stampfer; Hille 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 635 KB